LE
Luke Evnin
Proprietor at Annulus Cellars
United States
Overview
Luke Evnin is a Managing Director at MPM Capital and Chairman of the Scleroderma Research Foundation. He has successfully invested in companies like Werewolf Therapeutics and Photys Therapeutics, contributing to their growth and success in the pharmaceutical and biotech sectors.
Work Experience
Proprietor
2020 - Current
Chairperson
2016
Founder, Start-up CEO, Chairman
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Raised $178,172,597.00 from MPM Capital, UPMC Enterprises, Longwood Fund, DC Investment Partners, Taiho Ventures, RA Capital Management, Sphera Global Healthcare Fund, Soleus Capital, HBM Healthcare Investments and Adage Capital Management.
Managing Director
1997
MPM BioImpact is a biotechnology investment firm specializing in managing early-stage venture and private/public impact.
Chairperson
1999
Scleroderma Research Foundation is a onprofit investor in medical research to discover improved treatments and a cure for scleroderma.
General Partner
1990 - 1997